Enhancement of Anti-influenza A Virus Cytotoxicity Following Influenza A Virus Vaccination in Older, Chronically Ill Adults

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 1990 Nov 1

PMID 2123886

Citations 21

Authors

G J Gorse

R B Belshe

Affiliations

Soon will be listed here.

Abstract

We studied anti-influenza cytotoxicity by bulk peripheral blood mononuclear leukocyte (PBL) cultures derived from older, chronically ill volunteers undergoing vaccination. Vaccinees received either cold-recombinant, live-attenuated influenza A/Korea/1/82 (H3N2) virus intranasally or inactivated monovalent influenza A/Taiwan/1/86 (H1N1) subvirion vaccine intramuscularly. PBL were collected pre- and postvaccination and in vitro stimulated by autologous PBL infected with influenza A virus homologous and heterosubtypic to the respective vaccine strain. Cytotoxicity was measured against influenza A virus-infected autologous and human leukocyte antigen (HLA)-mismatched PBL targets infected with influenza A virus homologous or heterosubtypic to the vaccine virus strain. Vaccinees infected with the live-attenuated virus developed significant rises in mean anti-influenza, HLA-restricted cytotoxicity that was cross-reactive against influenza A viruses homologous and heterosubtypic to the vaccine virus. The enhanced cross-reactive cytotoxicity was inducible postvaccination by in vitro stimulation with autologous PBL infected with the homologous influenza A (H3N2) virus and with influenza A (H1N1) virus. In contrast, after vaccination with inactivated monovalent subvirion vaccine, volunteers developed significant increases in mean anti-influenza, HLA-restricted cytotoxicity only against autologous PBL infected with homologous influenza A (H1N1) virus. Increased cytotoxicity occurred only after in vitro stimulation with autologous cells infected with homologous influenza A (H1N1) virus. Mean gamma interferon levels in supernatant fluids of influenza A virus-stimulated effector PBL did not increase postvaccination, despite increased levels of anti-influenza cytotoxicity displayed by the effector cells. We conclude that the live-attenuated influenza A virus infection induced a broader range of enhanced anti-influenza cytotoxicity than did the inactivated subvirion vaccine.

Citing Articles

Comparison of vaccination efficacy using live or ultraviolet-inactivated influenza viruses introduced by different routes in a mouse model.

Baek K, Maharjan S, Akauliya M, Thapa B, Kim D, Kim J PLoS One. 2022; 17(10):e0275722.

PMID: 36215268 PMC: 9550053. DOI: 10.1371/journal.pone.0275722.

The use of cell-mediated immunity for the evaluation of influenza vaccines: an upcoming necessity.

Gianchecchi E, Torelli A, Montomoli E Hum Vaccin Immunother. 2019; 15(5):1021-1030.

PMID: 30614754 PMC: 6605831. DOI: 10.1080/21645515.2019.1565269.

Reversion of Cold-Adapted Live Attenuated Influenza Vaccine into a Pathogenic Virus.

Zhou B, Meliopoulos V, Wang W, Lin X, Stucker K, Halpin R J Virol. 2016; 90(19):8454-63.

PMID: 27440882 PMC: 5021423. DOI: 10.1128/JVI.00163-16.

Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine.

Mbawuike I, Atmar R, Patel S, Corry D, Winokur P, Brady R Vaccine. 2015; 34(4):547-554.

PMID: 26657997 PMC: 4713282. DOI: 10.1016/j.vaccine.2015.11.055.

Progress toward the development of universal influenza vaccines.

Hoft D, Belshe R Mo Med. 2014; 111(4):321-5.

PMID: 25211862 PMC: 6179460.

References

Boyum A . Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968; 97:77-89. View

Yap K, Ada G . The recovery of mice from influenza virus infection: adoptive transfer of immunity with immune T lymphocytes. Scand J Immunol. 1978; 7(5):389-97. DOI: 10.1111/j.1365-3083.1978.tb00469.x. View

McMichael A, Askonas B . Influenza virus-specific cytotoxic T cells in man; induction and properties of the cytotoxic cell. Eur J Immunol. 1978; 8(10):705-11. DOI: 10.1002/eji.1830081007. View

Biddison W, Shaw S, Nelson D . Virus specificity of human influenza virus-immune cytotoxic T cells. J Immunol. 1979; 122(2):660-4. View

Cox N, Maassab H, Kendal A . Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25 degrees between recent H3N2 and H1N1 epidemic.... Virology. 1979; 97(1):190-4. DOI: 10.1016/0042-6822(79)90386-6. View

Greenberg S, Six H, Drake S, Couch R . Cell cytotoxicity due to specific influenza antibody production in vitro after recent influenza antigen stimulation. Proc Natl Acad Sci U S A. 1979; 76(9):4622-6. PMC: 411631. DOI: 10.1073/pnas.76.9.4622. View

Reichman R, Pons V, Murphy B, Caplan E, Dolin R . Cell-mediated cytotoxicity following influenza infection and vaccination in humans. J Med Virol. 1979; 4(1):1-14. DOI: 10.1002/jmv.1890040102. View

Webster R, Askonas B . Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice. Eur J Immunol. 1980; 10(5):396-401. DOI: 10.1002/eji.1830100515. View

Phelan M, Mayner R, Bucher D, Ennis F . Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagents. J Biol Stand. 1980; 8(3):233-42. DOI: 10.1016/s0092-1157(80)80039-4. View

10.

Murphy B, Phelan M, Nelson D, Yarchoan R, Tierney E, Alling D . Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses. J Clin Microbiol. 1981; 13(3):554-60. PMC: 273830. DOI: 10.1128/jcm.13.3.554-560.1981. View

11.

Ennis F, Meager A . Immune interferon produced to high levels by antigenic stimulation of human lymphocytes with influenza virus. J Exp Med. 1981; 154(5):1279-89. PMC: 2186530. DOI: 10.1084/jem.154.5.1279. View

12.

Ennis F, Rook A, Qi Y, Schild G, Riley D, Pratt R . HLA restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccines. Lancet. 1981; 2(8252):887-91. DOI: 10.1016/s0140-6736(81)91389-1. View

13.

Lamb J, Eckels D, Lake P, Johnson A, Hartzman R, Woody J . Antigen-specific human T lymphocyte clones: induction, antigen specificity, and MHC restriction of influenza virus-immune clones. J Immunol. 1982; 128(1):233-8. View

14.

Belshe R, Van Voris L, MUFSON M . Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial. J Infect Dis. 1982; 145(3):311-9. DOI: 10.1093/infdis/145.3.311. View

15.

Ennis F, Schild G . Antibody and cytotoxic T lymphocyte responses of humans to live and inactivated influenza vaccines. J Gen Virol. 1982; 58(Pt 2):273-81. DOI: 10.1099/0022-1317-58-2-273. View

16.

Murphy B, Nelson D, Wright P, Tierney E, Phelan M, Chanock R . Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines. Infect Immun. 1982; 36(3):1102-8. PMC: 551444. DOI: 10.1128/iai.36.3.1102-1108.1982. View

17.

Mak N, Zhang Y, Ada G, Tannock G . Humoral and cellular responses of mice to infection with a cold-adapted influenza A virus variant. Infect Immun. 1982; 38(1):218-25. PMC: 347722. DOI: 10.1128/iai.38.1.218-225.1982. View

18.

McMichael A, Gotch F, Noble G, Beare P . Cytotoxic T-cell immunity to influenza. N Engl J Med. 1983; 309(1):13-7. DOI: 10.1056/NEJM198307073090103. View

19.

Lukacher A, Braciale V, Braciale T . In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J Exp Med. 1984; 160(3):814-26. PMC: 2187390. DOI: 10.1084/jem.160.3.814. View

20.

Kaplan D, Griffith R, Braciale V, Braciale T . Influenza virus-specific human cytotoxic T cell clones: heterogeneity in antigenic specificity and restriction by class II MHC products. Cell Immunol. 1984; 88(1):193-206. DOI: 10.1016/0008-8749(84)90064-9. View